Drugs

IND Application Reporting: Overview

Sponsors of IND applications are responsible for sending periodic updates and reports related to their applications to FDA. All submissions with IND application amendments or reports should include Form 1571 (PDF - 830KB) sent along with the respective amendment or report.

Form 3674 (PDF - 3MB) should be submitted for all new clinical trials.

Form 1572 (PDF - 718KB) should be included if the amendment concerns change in application sponsor or addition of a new investigator.

For any given IND application, FDA may receive the following categories of amendments and reports:

 

Page Last Updated: 10/08/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.